Index of reports
> Disability (77)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 77 Next >>
Possible Velcade side effects in 17 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: 17 year old female, weighing 42.7 kg (93.9 pounds)
Reactions: Flushing, Oral Pain, Skin Exfoliation, Pain of Skin, Peripheral Sensory Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Start date: 2012-06-09
End date: 2012-07-14
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-14
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Possible Velcade side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 88.4 kg (194.6 pounds)
Reactions: Back Pain, Renal Failure, Pain in Extremity, Anaemia, Joint Effusion, Deep Vein Thrombosis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2011-07-14
Aredia
Dosage: unk
Indication: Hypercalcaemia
Start date: 2011-03-07
End date: 2011-07-14
Decadron
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2011-07-14
Revlimid
Dosage: 25 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-25
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2011-07-14
Velcade
Dosage: 2.6 mg, cyclic
Start date: 2011-07-25
End date: 2012-04-23
Other drugs received by patient: B12-Vitamin
Possible Velcade side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: female
Reactions: Weight Decreased, Abasia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in 17 year old female
Reported by a physician from United States on 2012-08-03
Patient: 17 year old female, weighing 42.7 kg (93.9 pounds)
Reactions: Flushing, Skin Exfoliation, Oral Pain, Pain of Skin, Peripheral Sensory Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-14
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-14
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Possible Velcade side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-02
Patient: female
Reactions: Neuropathy Peripheral, Peroneal Nerve Palsy, Herpes Zoster
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in
Reported by a physician from Japan on 2012-07-30
Patient:
Reactions: Illusion, Quadriplegia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dexamethasone
Possible Velcade side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Velcade
End date: 2012-04-10
Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-07-26
Patient:
Reactions: Physical Disability
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-07-23
Patient:
Reactions: Neuropathy Peripheral, Pain, Mobility Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Butrans; Gabapentin; Diazepam; Amitriptyline HCL; Diazepam
Possible Velcade side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore
Possible Velcade side effects in
Reported by a physician from Japan on 2012-07-16
Patient:
Reactions: Illusion, Quadriplegia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dexamethasone
Possible Velcade side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: female
Reactions: Death, Neuropathy Peripheral, Fatigue, Diarrhoea, Colitis Microscopic
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Revlimid
Dosage: 25 mg, qd
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-04-01
End date: 2010-12-01
Revlimid
Dosage: 25 mg, qd
Administration route: Oral
Start date: 2011-01-01
End date: 2011-03-01
Velcade
Dosage: 2.4 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2009-12-01
End date: 2010-09-01
Other drugs received by patient: Aredia; Dexamethasone Sodium Posphate
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: male, weighing 88.4 kg (194.6 pounds)
Reactions: Back Pain, Renal Failure, Pain in Extremity, Anaemia, Joint Effusion
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2011-07-14
Aredia
Dosage: unk
Indication: Hypercalcaemia
Start date: 2011-03-07
End date: 2011-07-14
Decadron
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2011-07-14
Revlimid
Dosage: 25 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-25
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2011-07-14
Velcade
Dosage: 2.6 mg, cyclic
Start date: 2011-07-25
End date: 2012-04-23
Other drugs received by patient: B12-Vitamin
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: female, weighing 86.2 kg (189.6 pounds)
Reactions: Spinal Cord Compression, Paraplegia, Vomiting, Nausea, Oesophagitis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dilaudid; Zometa; Oxycontin; Revlimid
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-07-11
Patient: female, weighing 96.0 kg (211.2 pounds)
Reactions: Myalgia, Neuropathy Peripheral, Muscular Weakness, Neuralgia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: days 1-4, 9-12, 17-20 of cycle
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-10-30
Dexamethasone
Dosage: 1 in 1 month
Administration route: Oral
Start date: 2010-01-29
Dexamethasone
Dosage: days 1-4
Administration route: Oral
Start date: 2009-12-14
Doxorubicin HCL
Dosage: on day 1
Start date: 2009-12-14
Doxorubicin HCL
Dosage: on day 1
Start date: 2010-01-28
Doxorubicin HCL
Dosage: on day 1
Indication: Multiple Myeloma
Start date: 2009-10-30
Velcade
Dosage: days 1,4,8,11 of cycle
Start date: 2009-12-14
Velcade
Dosage: days 1,4,8,11 of cycle
Start date: 2010-01-28
Velcade
Dosage: days 1,4,8,11 of cycle
Indication: Multiple Myeloma
Start date: 2009-10-30
Possible Velcade side effects in
Reported by a physician from Spain on 2012-07-11
Patient:
Reactions: Myopathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Influenza Vaccine
Indication: Prophylaxis
Interferon Alfa-2B
Dosage: 1.5 unk, unk
Indication: Multiple Myeloma
Start date: 2008-04-28
End date: 2011-02-02
Thalidomide
Dosage: 100 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-06-05
End date: 2007-11-10
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2007-06-05
End date: 2007-11-02
Possible Velcade side effects in
Reported by a physician from Japan on 2012-07-10
Patient:
Reactions: Atelectasis, Interstitial Lung Disease, Haemorrhage, Cytomegalovirus Oesophagitis, Pleural Effusion, Blood Pressure Decreased, Oesophageal Ulcer
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dexamethasone
Possible Velcade side effects in
Reported by a pharmacist from United States on 2012-07-05
Patient:
Reactions: Product Quality Issue, Intraocular Pressure Increased, Visual Acuity Reduced, Inflammation
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in female
Reported by a physician from United States on 2012-07-05
Patient: female
Reactions: Death, Neuropathy Peripheral, Fatigue, Colitis Microscopic
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-01-01
End date: 2011-03-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-04-01
End date: 2010-12-01
Velcade
Dosage: 2.4 milligram
Start date: 2009-12-01
End date: 2010-09-01
Other drugs received by patient: Dexamethasone Sodium Phosphate; Aredia
Possible Velcade side effects in
Reported by a physician from United States on 2012-07-02
Patient:
Reactions: Off Label Use, Wrong Drug Administered, Eye Inflammation, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Povidone Iodine; Ofloxacin; Mucaine / 00115701 /; Proparacaine Hydrochloride
Possible Velcade side effects in
Reported by a pharmacist from United States on 2012-07-02
Patient:
Reactions: Off Label Use, Wrong Drug Administered, Eye Inflammation, Intraocular Pressure Increased, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Lidocaine; Proparacaine HCL; Povidone Iodine; Ofloxacin
Possible Velcade side effects in
Reported by a pharmacist from United States on 2012-07-02
Patient:
Reactions: Off Label Use, Eye Inflammation, Wrong Drug Administered, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Povidone Iodine; Ofloxacin; Proparacaine Hydrochloride
Possible Velcade side effects in
Reported by a pharmacist from United States on 2012-07-02
Patient:
Reactions: Off Label Use, Intraocular Pressure Increased, Eye Inflammation, Wrong Drug Administered, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Ofloxacin; Piperocaine; Lidocaine; Povidone Iodine
Possible Velcade side effects in
Reported by a pharmacist from United States on 2012-07-02
Patient:
Reactions: Off Label Use, Wrong Drug Administered, Eye Inflammation, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Povidone Iodine; Lidocaine; Proparacaine Hydrochloride; Ofloxacin
Possible Velcade side effects in
Reported by a pharmacist from Canada on 2012-06-29
Patient:
Reactions: Guillain-Barre Syndrome
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Repaglinide; Eprex; Dexamethasone; Revlimid; Lactulose; Pamidronate Disodium; Crestor; Gamma Globulin / 00025201 /; Diltiazem Hydrocholoride; Lansoprazole
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: male, weighing 128.1 kg (281.8 pounds)
Reactions: Musculoskeletal Pain, Anaemia, Mental Status Changes, Multiple Myeloma, Hypercalcaemia, Osteonecrosis, Fatigue, Gait Disturbance, Thrombocytopenia, Pathological Fracture
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytoxan
Dexamethasone
Indication: Product Used FOR Unknown Indication
Etoposide
Indication: Product Used FOR Unknown Indication
Revlimid
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: unk
Start date: 2012-05-03
Velcade
Dosage: 1.3 mg, cyclic
Indication: Multiple Myeloma
Start date: 2012-03-07
End date: 2012-04-23
Other drugs received by patient: Metoprolol Succinate; Ramipril; Duloxetime Hydrochloride; Glucophage; Catapres / 00171101 /; Allopurinol; Cymbalta; Percocet; Zometa; Ativan; Ascriptin A / D
Possible Velcade side effects in
Reported by a pharmacist from United States on 2012-06-08
Patient:
Reactions: Off Label Use, Eye Inflammation, Wrong Drug Administered, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Mucaine / 00115701 /; Proparacaine Hydrochloride; Povidone-Iodine (Formula 47); Ofloxacin
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-06-08
Patient:
Reactions: Off Label Use, Eye Inflammation, Wrong Drug Administered, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Proparacaine Hydrochloride; Ofloxacin; Povidone-Iodine (Formula 47)
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-06-08
Patient:
Reactions: Off Label Use, Wrong Drug Administered, Intraocular Pressure Increased, Eye Inflammation, Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Piperocaine; Povidone-Iodine (Formula 47); Ofloxacin; Lidocaine
Page 1 Next >>
|